← Eichor
Study identifier: NCT06838039 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessing the Impact of Additional Serratus Anterior Block Within 24-Hour on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients

Condition: Post Operative Pain · VATS  ·  Sponsor: Al-Quds University

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Title: Assessing the Impact of Additional Serratus Anterior Block on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients Purpose: This randomized controlled trial aims to evaluate whether the addition of a Serratus Anterior Plane Block (SAPB) to the standard Rhomboid Intercostal Block (RIB) improves postoperative pain management in patients undergoing Video-Assisted Thoracoscopic Surgery (VATS). Study Design: * Type: Randomized Controlled Trial (RCT) * Participants: 50 patients aged 18 -70 requiring VATS, randomized into two groups: one receiving RIB alone, and the other receiving RIB + SAPB. * Duration: Pain and opioid consumption will be measured within 48 hours post-surgery. * Outcome Measures: Pain levels using the Visual Analog Scale (VAS), opioid usage, and patient satisfaction. Significance: The study addresses the gap in research regarding the combined use of SAPB and RIB in pain control for VATS. It hypothesizes that the combination will lead to better pain relief and reduced opioid dependence compared to RIB alone.

This description comes directly from the study's public registry record.

Talk to the study team

Mohammed Adel Adwan, MD  ·  00970594393480  ·  maadwan123m@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Al Ahli hospitalHebron, Palestinian TerritoriesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06838039